Additionally, molecular analysis of CTC samples revealed that the expression of the candidate docetaxel-resistance gene ADAMTS1, and EMT transcription factors ZEB1 and SNAI1 along with the PCa specific kallikreins KLK2 and KLK4 significantly correlated with poor mHSPC patient outcome. The gene discussed is ZEB1; the disease is posterior cortical atrophy.